Elliott, M., Favre-Guilmard, C., Liu, S. M., Maignel, J., Masuyer, G., Beard, M., . . . Krupp, J. (2019). Engineered botulinum neurotoxin B with improved binding to human receptors has enhanced efficacy in preclinical models. Sci Adv.
Citação norma ChicagoElliott, Mark, et al. "Engineered Botulinum Neurotoxin B With Improved Binding to Human Receptors Has Enhanced Efficacy in Preclinical Models." Sci Adv 2019.
Citação norma MLAElliott, Mark, et al. "Engineered Botulinum Neurotoxin B With Improved Binding to Human Receptors Has Enhanced Efficacy in Preclinical Models." Sci Adv 2019.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.